Opioid Use Disorder Clinical Trials in The Bronx, New York

4 studies are recruiting for opioid use disorder in The Bronx, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Brenipatide in Participants With Opioid Use Disorder

    The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 14…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Adams Clinical Bronx, The Bronx, New York
    Locations
    59 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07420283 on ClinicalTrials.gov

  2. Low-dose Buprenorphine Initiation for Opioid Use Disorder

    The purpose of this study is to test whether low-dose buprenorphine initiation for treatment of opioid use disorder is safe and effective.

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Montefiore Medical Center, The Bronx, New York
    Run by
    Montefiore Medical Center

    See if you can join NCT05450718 on ClinicalTrials.gov

  3. E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

    The purpose of this an open-label, randomized controlled trial study is to compare the effectiveness of electronic cigarettes (e-cigarettes/e-cigs) versus telehealth motivational counseling with combination nicotine replacement therapy (NRT) + telehealth counseling on combustible cigarettes smoking…

    Stage
    Phase 2
    Ages
    21 to 75
    Site
    Albert Einstein College of Medicine, The Bronx, New York
    Locations
    2 in total
    Run by
    NYU Langone Health

    See if you can join NCT05722561 on ClinicalTrials.gov

  4. Psilocybin for Opioid Use Disorder (OUD)

    This is a double-blind, adaptive, 2-stage, multi-site, phase 2 randomized controlled clinical trial designed to evaluate effects of moderate and high dose psilocybin, relative to low-dose psilocybin control, in OUD patients who continue to use illicit opioids in spite of adherence to standard-of-ca…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    VIP Community Services, Inc, The Bronx, New York
    Locations
    5 in total
    Run by
    NYU Langone Health

    See if you can join NCT06796062 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.